Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Osborne, R. First novel anti-tuberculosis drug in 40 years. Nat Biotechnol 31, 89–90 (2013). https://doi.org/10.1038/nbt0213-89
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0213-89
- Springer Nature America, Inc.
This article is cited by
-
Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents
Molecular Diversity (2021)
-
Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis
Journal of Clinical Bioinformatics (2015)
-
The Political and Ethical Challenge of Multi-Drug Resistant Tuberculosis
Journal of Bioethical Inquiry (2015)
-
Speculative strategies for new antibacterials: all roads should not lead to Rome
The Journal of Antibiotics (2013)
-
Uridine monophosphate kinase as potential target for tuberculosis: From target to lead identification
Interdisciplinary Sciences: Computational Life Sciences (2013)